When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RHHBY - Roche's Xofluza successful in late-stage flu study
Roche Holding Ltd ADR
Results from a Phase 3 clinical trial, MINISTONE-2, evaluating an oral suspension formulation of Roche (OTCQX:RHHBY) unit Genentech's XOFLUZA (baloxavir marboxil) in children with the flu showed that it was well-tolerated and reduced the duration of flu symptoms.
More news on: Roche Holding AG, Shionogi & Co., Ltd., Healthcare stocks news,